SEL-037 (Pegsiticase)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SEL-037 (Pegsiticase), covering 2016-10-21 to 2016-10-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels [Phase 1]